Dr. Dovey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4401 Penn Ave
# Aob
Pittsburgh, PA 15224Phone+1 412-692-6021
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Pulmonology, 1994 - 1997
- Johns Hopkins UniversityResidency, Pediatrics, 1989 - 1992
- Duke University School of MedicineClass of 1989
Certifications & Licensure
- PA State Medical License 2007 - 2024
- MA State Medical License 1994 - 2017
- NY State Medical License 1992 - 2007
- WA State Medical License 1999 - 2001
- American Board of Pediatrics Pediatric Pulmonology
Publications & Presentations
PubMed
- 178 citationsA Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung DiseaseMoira L. Aitken, Richard B. Moss, David A. Waltz, Mark Dovey, Mark R. Tonelli
Human Gene Therapy. 2001-10-10 - 236 citationsSignificant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.Ronald L. Gibson, Julia Emerson, Sharon McNamara, Jane L. Burns, Margaret Rosenfeld
American Journal of Respiratory and Critical Care Medicine. 2003-03-15 - 120 citationsPopulation-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating in...Anne Marie Comeau, Richard B. Parad, Henry L. Dorkin, Mark Dovey, Robert S. Gerstle
Pediatrics. 2004-06-01
Other
- Acute asthma exacerbations in children: Inpatient managementDovey M
http://www.uptodate.com/contents/acute-asthma-exacerbations-in-children-inpatient-management
UpToDate, Wolters Kluwer Health - 2012-10-01
Grant Support
- Placebo-Controlled Oral Corticosteroid Therapy In CF PatientsNational Center For Research Resources2004
- Aerosolized Tgaavcf For Treatment Of Cystic FibrosisNational Center For Research Resources2000–2002
- Urinary Leukotriene E4 Levels As Marker Of Pulmonary Disease Progression In CFNational Center For Research Resources1999–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: